Effectiveness of Intraoperative Exparel for Postoperative Pain Control in Total Knee Arthroplasty
Status:
Unknown status
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
Does the use of periarticular Exparel in total knee arthroplasty prove to more effectively
manage post operative pain control than another local analgesic, Ropivacaine, when both are
used as part of a multimodal pain management approach?
The investigators hypothesize that Exparel, a bupivacaine liposomal injectable suspension,
will improve total knee arthroplasty postoperative pain with significant improvement of early
function outcomes.